Recently, stocks related to controlled nuclear fusion in China’s A-share market have surged collectively, with Zhefu Holding (002266.SZ) hitting its daily trading limit, drawing significant market attention. This rally is primarily driven by multiple positive catalysts: on one hand, global demand for clean energy continues to rise, and expectations of technological breakthroughs in controlled nuclear fusion—a promising future energy source—are strengthening; on the other hand, China is intensifying its investment in nuclear fusion research, including participation in the International Thermonuclear Experimental Reactor (ITER) project and advancing experiments with the EAST “artificial sun” device, creating new opportunities for companies in the related industrial chain. As a domestic high-end equipment manufacturer, Zhefu Holding operates in sectors such as nuclear power and hydropower equipment and has been actively expanding into nuclear fusion-related R&D and supporting equipment production, positioning it as a key player in the fusion concept stock category. Buoyed by heightened investor sentiment and anticipated policy support, its share price has risen sharply. However, industry experts caution that controlled nuclear fusion remains in the experimental and developmental phase, with commercialization still years away. Investors are advised to approach short-term speculation rationally and focus on companies’ long-term technological capabilities and tangible business progress.
近日，A股市场可控核聚变概念股集体走高，其中浙富控股（002266.SZ）强势涨停，引发市场广泛关注。此次板块上涨主要受多重利好消息推动：一方面，全球范围内对清洁能源的需求持续上升，可控核聚变作为未来能源的重要方向，技术突破预期增强；另一方面，中国在核聚变领域不断加大投入，如参与国际热核聚变实验堆（ITER）项目、推进“人造太阳”EAST装置实验等，为相关产业链企业带来发展机遇。浙富控股作为国内高端装备制造企业，其业务涵盖核电设备、水电设备等领域，并积极布局核聚变相关技术研发与配套设备制造，因此被市场视为核聚变概念的重要标的。投资者情绪高涨叠加政策支持预期，推动公司股价快速上扬。不过，业内专家也提醒，目前可控核聚变仍处于实验和研发阶段，距离商业化应用尚有较长周期，投资者应理性看待短期炒作，关注企业长期技术积累与实际业务进展。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/19473.html